Showing results (281-290 of 6,284) with videos related to

Sort By:
Pageof 629
Diabetes, Obesity & Metabolism|June 5, 2013
Hemin therapy suppresses inflammation and retroperitoneal adipocyte hypertrophy to improve glucose metabolism in obese rats co-morbid with insulin-resistant type-2 diabetesJ F Ndisang, A Jadhav
Diabetes, Obesity & Metabolism|March 28, 2013
Alogliptin versus glipizide monotherapy in elderly type 2 diabetes mellitus patients with mild hyperglycaemia: a prospective, double-blind, randomized, 1-year studyJ Rosenstock, C Wilson, P Fleck
Diabetes, Obesity & Metabolism|August 3, 2013
Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemiaJ Rosenstock, L J Seman, A Jelaska, et al.
Diabetes, Obesity & Metabolism|June 21, 2013
Differential effects of vildagliptin and glimepiride on glucose fluctuations in patients with type 2 diabetes mellitus assessed using continuous glucose monitoringY L He, G Foteinos, S Neelakantham, et al.
Diabetes, Obesity & Metabolism|June 21, 2013
A propensity score matched comparison of different insulin regimens 1 year after beginning insulin in people with type 2 diabetesN Freemantle, B Balkau, P D Home
Diabetes, Obesity & Metabolism|March 27, 2012
Pumpers, skypers, surfers and texters: technology to improve the management of diabetes in teenagersM A Harris, K K Hood, S A Mulvaney
Diabetes, Obesity & Metabolism|March 27, 2012
PPAR agonists for the treatment of cardiovascular disease in patients with diabetesJ P H Wilding
Diabetes, Obesity & Metabolism|June 1, 2012
Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findingsJ J Holst, T Vilsbøll
Diabetes, Obesity & Metabolism|June 2, 2012
Evaluation of body fat composition after linagliptin treatment in a rat model of diet-induced obesity: a magnetic resonance spectroscopy study in comparison with sibutramineT Klein, H G Niessen, C Ittrich, et al.
Diabetes, Obesity & Metabolism|March 14, 2002
Minor long-term changes in weight have beneficial effects on insulin sensitivity and beta-cell function in obese subjectsA M Rosenfalck, H Hendel, M H Rasmussen, et al.
Pageof 629